alzheon, Author at Alzheon | Preserving Future Memories - Page 15 of 21

About alzheon

This author has not yet filled in any details.
So far alzheon has created 208 blog entries.

17 Jul, 2017

ALZ-801 Mechanism of Action: Stoichiometry of Beta Amyloid Anti-Oligomer Effect, PK/PD, and Clinical Dose Selection for Confirmatory Phase 3 Program in Alzheimer’s Disease

alzheon2019-09-23T12:10:49-04:00July 17th, 2017|

17 Jul, 2017

Alzheon Presents New Data for Lead Candidate ALZ-801 on Novel MOA and Long-Term Clinical Efficacy at the Alzheimer’s Association International Conference

alzheon2024-08-02T10:28:55-04:00July 17th, 2017|

23 Jun, 2017

Alzheon says data backs potential of Alzheimer’s candidate

alzheon2019-09-23T12:10:49-04:00June 23rd, 2017|Tags: PMLiVE|

22 Jun, 2017

Alzheon to Present Novel Molecular Mechanism of Action and Long Term Clinical Efficacy Data for Lead Candidate ALZ-801 at the Alzheimer’s Association International Conference

alzheon2024-08-02T11:15:45-04:00June 22nd, 2017|

22 Jun, 2017

Clinical Effects Of Tramiprosate In APOE4/4 Homozygous Patients With Mild Alzheimer’s Disease Suggest Disease Modification Potential

alzheon2019-09-23T12:10:49-04:00June 22nd, 2017|

22 Jun, 2017

Alzheon Publishes New Analyses Showing Clinical Benefit of Tramiprosate in APOE4/4 Homozygous Patients at the Mild Stage of Alzheimer’s Disease; Clinical Effects Suggest Disease Modification Potential and Align with Preclinical Effects on Beta Amyloid Oligomer Formation

alzheon2024-08-02T11:26:03-04:00June 22nd, 2017|

6 Jun, 2017

Beta Amyloid Anti-Oligomer Action of ALZ-801 and Clinical Dose Translation Analyses Support Confirmatory Phase 3 Program in Alzheimer’s Disease

alzheon2019-09-23T12:10:49-04:00June 6th, 2017|

2 Jun, 2017

Insights from discovery through clinical efficacy to support a new class of therapeutics in Alzheimer’s disease

alzheon2019-09-23T12:10:49-04:00June 2nd, 2017|Tags: Drug Target Review|

25 Apr, 2017

Alzheon Scientists Discover Novel Therapeutic Mechanism of Inhibition of Formation of Toxic Beta Amyloid Oligomers, Key Driver of Alzheimer’s Disease Pathogenesis

alzheon2024-08-05T18:26:31-04:00April 25th, 2017|

24 Apr, 2017

What Went Wrong in Alzheimer’s? A fireside chat with Nobel Laureate Dr. Stanley Prusiner

alzheon2020-06-26T16:57:49-04:00April 24th, 2017|